SEC Form 4 · accession 0001213900-19-003738
Actinium Pharmaceuticals, Inc. · ATNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Stanley Berger
Officer — Chief Medical Officer
Period of report
Mar 5, 2019
Accepted (ET)
Mar 7, 2019 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 5, 2019 | X | 3,500 | $0.60 | A | 22,500 | D |
Table II — derivative securities
No Table II lines on this filing.